DAS28 Rheumatoid Arthritis Score
Calculate DAS28-ESR or DAS28-CRP to assess rheumatoid arthritis disease activity and determine remission, low, moderate, or high activity status.
DAS28 Inputs
0 = no activity, 100 = maximum activity
Enter values on the left and click Calculate DAS28 to see the score.
DAS28 Score
ESR—
EULAR disease activity
0
2.6
3.2
5.1
9.4
Clinical Interpretation
Formula Breakdown
√TJC28
√SJC28
ln(ESR)
PGA term
EULAR Activity Thresholds
| Category | DAS28 Range | Typical Guidance |
|---|---|---|
| Remission | < 2.6 | Maintain therapy; consider tapering |
| Low Activity | 2.6 – 3.2 | Consider maintaining or cautious taper |
| Moderate Activity | 3.2 – 5.1 | Optimize DMARDs; consider step-up |
| High Activity | > 5.1 | Escalate therapy; consider biologics |
Summary
Calculate DAS28-ESR or DAS28-CRP to assess rheumatoid arthritis disease activity and determine remission, low, moderate, or high activity status.
How it works
- Select the variant: DAS28-ESR (uses erythrocyte sedimentation rate) or DAS28-CRP (uses C-reactive protein).
- Enter the 28 Tender Joint Count (TJC28) — the number of joints that are painful on pressure or passive movement.
- Enter the 28 Swollen Joint Count (SJC28) — the number of joints with soft-tissue swelling.
- Enter the ESR (mm/hr) or CRP (mg/L) laboratory value for the inflammatory marker.
- Enter the Patient Global Assessment (PGA) on a 0–100 mm visual analog scale (0 = no activity, 100 = maximum activity).
- Click Calculate to see the DAS28 score and EULAR disease activity category.
Use cases
- Monitor disease activity at each clinic visit for patients with rheumatoid arthritis.
- Define remission (DAS28 < 2.6) as a treatment target in treat-to-target strategies.
- Assess response to biologic or DMARD therapy using EULAR response criteria.
- Document disease burden for insurance authorization of biologic agents.
- Compare pre- and post-treatment scores to quantify therapeutic benefit.
- Support clinical trial enrollment and outcome reporting.
- Educate patients on their current disease activity level in a standardized way.
- Differentiate low, moderate, and high activity states to guide escalation decisions.
Frequently Asked Questions
Related tools
Last updated: 2026-05-23 ·
Reviewed by Nham Vu